# Endophenotype for Alcohol Misuse in Healthy Minority Populations

> **NCT00256451** · PHASE4 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 43 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Naltrexone
- **DRUG:** placebo
- **OTHER:** alcohol
- **OTHER:** Sham alcohol

## Key facts

- **NCT ID:** NCT00256451
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2019-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00256451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00256451, "Endophenotype for Alcohol Misuse in Healthy Minority Populations". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00256451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*